Veterinary Medicines

Wellplus Flavoured Tablets

Authorised
  • Praziquantel
  • Pyrantel embonate
  • Febantel
Download as PDF

Product identification

Medicine name:
Wellplus Flavoured tablets for Dogs
Wellplus Flavoured Tablets
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Febantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA30
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • box containing 300 tablets (30 blisters)
  • box containing 100 tablets (10 blisters)
  • box containing 50 tablets (5 blisters)
  • box containing 20 tablets (2 blisters)
  • box containing 10 tablets (1 blister)
  • box containing 2 tablets (1 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10505/003/001
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0163/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Germany
  • Greece
  • Ireland
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

eu-PUAR-wellplus-flavoured-tablets-en.pdf

English (PDF)
Published on: 11/04/2023
Download